Brief: NextCure Reports Q4 and Full Year 2021 Financial Results
March 3 (Reuters) - NextCure Inc NXTC.O :
* NEXTCURE PROVIDES BUSINESS UPDATE AND REPORTS FOURTH
QUARTER AND
FULL YEAR 2021 FINANCIAL RESULTS
* NEXTCURE INC - ENDS 2021 WITH CASH POSITION OF $219.6
MILLION
THAT IS EXPECTED TO FUND OPERATIONS INTO Q1 OF 2024
* NEXTCURE INC - MULTIPLE DATA READOUTS EXPECTED IN 2022,
INCLUDING UPDATES FOR ALL THREE CLINICAL PROGRAMS OF NC318,
NC410 AND NC762
Source text for Eikon: ID:nGNX7VqfJW
Further company coverage: NXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview